002287SZSE

2025 Annual Performance Brief

Tibet Cheezheng Tibetan Medicine Co., Ltd.·February 13, 2026·2 pages

✨ AI Summary

This announcement presents the preliminary financial results for Qizheng Tibetan Medicine Co., Ltd. for the year 2025. The company reported a total revenue of 241.6 million yuan, a 3.34% increase from the previous year, and a net profit attributable to shareholders of 64.6 million yuan, up 10.98%. The figures are subject to change as they have not been audited by an external accounting firm.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Securities Code: 002287

Securities Abbreviation: Qizheng Tibetan Medicine

Announcement Number: 2026-006

Qizheng Tibetan Medicine Co., Ltd. 2025 Annual Performance Brief

The company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Special Reminder: The financial data for the year 2025 contained in this announcement is preliminary accounting data, audited by the internal audit department of Qizheng Tibetan Medicine Co., Ltd. (hereinafter referred to as "the Company"), and has not been audited by an accounting firm. There may be differences from the final data disclosed in the annual report; investors should be aware of investment risks.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.